Neurobiology of AgingNeurosciencePeer-reviewed journal article
Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia
Isabelle GuisleiD, Geoffrey CanetiD, Séréna Petry, Parissa Fereydouni-ForouzandehiD, Françoise MoriniD, Rémi Kérauden, Robert A. WhittingtoniD, Frédéric CaloniD, Sébastien S. HébertiD, Emmanuel PlaneliD
Abstract
In Alzheimers disease (AD), hyper-phosphorylation and aggregation of tau correlates with clinical progression and represents a valid therapeutic target. A recent 20-year prospective study revealed an association between moderate to high frequency of Finnish sauna bathing and a lower incidence of dementia and AD, but the molecular mechanisms underlying these benefits remain uncertain. Here, we tested the hypothesis that sauna-like conditions could lower tau phosphorylation by increasing body temperature. We observed a decrease in tau phosphorylation in wild-type and hTau mice as well as in neuron-like cells when exposed to higher temperatures. These effects were correlated with specific changes in phosphatase and kinase activities, but not with inflammatory or heat-shock responses. We also used a drug strategy to promote thermogenesis. Topical application of menthol led to a sustained increase in body temperature in hTau mice concomitant with a significant decrease in tau phosphorylation. Our results suggest that sauna-like conditions or menthol treatment could lower tau pathology through mild hyperthermia, and may provide promising therapeutic strategies for AD and other tauopathies.
- Citations
- 23
- FWCI
- 2.78
- Field percentile
- top 9%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synthetic torpor triggers a neuroprotective and regulated mechanism in the rat brain, favoring the reversibility of Tau protein hyperphosphorylation.
Fabio Squarcio, Timna Hitrec, … Marco Luppi·Frontiers in PhysiologyPeer-reviewed·Mar 9, 2023
- Hyperphosphorylated Tau Inflicts Intracellular Stress Responses That Are Mitigated by Apomorphine
Z. Song, K.-W. Wang, … M.-H. Kuo·bioRxiv·May 13, 2023
- Behavioral dysregulation and monoaminergic deficits precede memory impairments in human tau-overexpressing (htau) mice
K. M. Khan, G. P. Selvakumar, … C. A. Marcinkiewcz·bioRxiv·Apr 3, 2022
- Targeting mTOR restores tau-induced metabolic, mitochondrial, and cognitive deficits in a tauopathy mouse model
Zhi Tang, Min Guo, … Xiaolan Qi·bioRxiv·Nov 24, 2024
- A conserved serotonin receptor pathway is a druggable modifier of Tau pathology, neural circuit formation and neurodegeneration
Mariana I Tsap, Valeriya Navrotskaya, … Halyna R. Shcherbata·bioRxiv·Aug 27, 2026
- Tau phosphorylated at serine 356 is associated with Alzheimer's disease pathology and can be lowered in mouse and human brain tissue using the NUAK inhibitor WZ4003
Lewis W. Taylor, Elizabeth M. Simzer, … Claire S. Durrant·Acta NeuropathologicaPeer-reviewed·Jan 4, 2024